Arlo Technologies, Inc. - 10-Q Summary (Q2 2026)
Business Context and Reporting Period
This report covers the quarterly period ended June 28, 2026. Arlo Technologies, Inc. operates as a single segment providing smart home security devices and subscription services globally. The company reported its first profitable quarter in recent history, driven by strong subscription growth and strategic acquisitions.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | Q2 2025 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|---|
| Total Revenue | $155.9 million | $129.4 million | $306.3 million | $248.5 million |
| Gross Profit | $75.2 million | $58.1 million | $147.9 million | $110.8 million |
| Gross Margin | 48.2% | 44.9% | 48.3% | 44.6% |
| Net Income | $3.0 million | $3.1 million | $17.9 million | $2.3 million |
| Diluted EPS | $0.03 | $0.03 | $0.16 | $0.02 |
| Operating Cash Flow (YTD) | $39.3 million | $39.7 million | $39.3 million | $39.7 million |
| Cash & Investments | $141.1 million (as of June 28, 2026) | |||
| Debt | $0 (No borrowings under $45M credit facility) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 20.5% year-over-year (Q2) and 23.3% year-over-year (YTD). Subscriptions and services revenue grew 19.0% (Q2) and 24.6% (YTD), while product revenue grew 22.8% (Q2) and 21.4% (YTD).
- Profitability: Income from operations improved significantly to $2.5 million in Q2 2026 from $1.9 million in Q2 2025. YTD operating income reached $10.0 million compared to $0.5 million in the prior year.
- Acquisitions: The company completed two major acquisitions in Q2 2026:
- Canary Connect: Acquired for ~$48.9 million (cash and deferred consideration) to expand AI-driven smart home security.
- Aloe Care Health: Acquired for ~$19.5 million (cash and earnout) to enter the AI-powered medical alert and fall prevention market.
- Tariff Refunds: Recognized $8.0 million in tariff refunds as a reduction of cost of revenue in Q2 2026, following a Supreme Court ruling on IEEPA tariffs.
- Investment Gain: Recorded a one-time gain of $6.4 million from the sale of a long-term strategic investment in Q1 2026, contributing to YTD net income.
Guidance, Outlook, and Risks
- Outlook: Management expects to increase investment in R&D to launch new products and compete for engineering talent. Sales and marketing expenses are expected to rise to drive demand.
- Stock Repurchases: The Board authorized a $50.0 million repurchase program in February 2026. As of June 28, 2026, the company repurchased 2.3 million shares for $29.9 million, with $20.1 million remaining available.
- Liquidity: The company maintains $141.1 million in cash and short-term investments and has $45.0 million in unused borrowing capacity under its revolving credit facility.
- Risks:
- Customer Concentration: One customer accounted for 40% of total revenue in the first six months of 2026.
- Geopolitical/Tariffs: Ongoing uncertainty regarding global trade policies and tariffs could impact supply chains and costs.
- Valuation Allowance: The company maintains a full valuation allowance against U.S. deferred tax assets, citing insufficient evidence of sustained profitability to realize them, though this may change in future quarters.
Investor Verification Checklist
- Customer Concentration: Verify the stability and contract terms of the single customer representing 40% of revenue.
- Acquisition Integration: Monitor the integration progress and revenue contribution of Canary Connect and Aloe Care Health.
- Tariff Refund Sustainability: Confirm that the $8.0 million tariff refund is a one-time benefit and not a recurring cost reduction.
- Deferred Tax Assets: Watch for future announcements regarding the release of the valuation allowance on deferred tax assets as profitability stabilizes.
- Stock Repurchase Pace: Track the utilization of the remaining $20.1 million repurchase authorization and its impact on share count.